Cargando…

The association between daytime napping and risk of type 2 diabetes is modulated by inflammation and adiposity: Evidence from 435 342 UK‐Biobank participants

BACKGROUND: Existing evidence concerning the relationship between daytime napping and type 2 diabetes (T2D) is inconsistent, and whether the effects of napping differ by body fat percentage (BFP) and C‐reactive protein (CRP) is unclear. We aimed to investigate the association between daytime napping...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Rui, Chen, Hao‐Wen, Huang, Yi‐Ning, Zhong, Qi, Li, Fu‐Rong, Huang, Rui‐Dian, Liu, Hua‐Min, Zheng, Jia‐Zhen, Xu, Jia‐Wen, Wu, Xian‐Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270744/
https://www.ncbi.nlm.nih.gov/pubmed/37052293
http://dx.doi.org/10.1111/1753-0407.13387
_version_ 1785059379800702976
author Zhou, Rui
Chen, Hao‐Wen
Huang, Yi‐Ning
Zhong, Qi
Li, Fu‐Rong
Huang, Rui‐Dian
Liu, Hua‐Min
Zheng, Jia‐Zhen
Xu, Jia‐Wen
Wu, Xian‐Bo
author_facet Zhou, Rui
Chen, Hao‐Wen
Huang, Yi‐Ning
Zhong, Qi
Li, Fu‐Rong
Huang, Rui‐Dian
Liu, Hua‐Min
Zheng, Jia‐Zhen
Xu, Jia‐Wen
Wu, Xian‐Bo
author_sort Zhou, Rui
collection PubMed
description BACKGROUND: Existing evidence concerning the relationship between daytime napping and type 2 diabetes (T2D) is inconsistent, and whether the effects of napping differ by body fat percentage (BFP) and C‐reactive protein (CRP) is unclear. We aimed to investigate the association between daytime napping frequency and T2D risk and whether such an association was modified by BFP and CRP. METHODS: We included 435 342 participants free of diabetes from the UK Biobank. Participants were categorized as nonnappers, occasional nappers, and frequent nappers based on napping frequency, and BFP/CRP was divided into quartiles. Cox proportional hazards models were used. RESULTS: During a median follow‐up of 9.2 years, 17 592 T2D cases occurred. Higher frequency of daytime napping was significantly associated with an increased risk of T2D. Compared with nonnappers, the adjusted hazard ratios (HRs) for occasional nappers and habitual nappers were 1.28 (95% confidence interval [CI]: 1.24–1.32) and 1.49 (95% CI: 1.41–1.57), respectively. There was a significant additive and multiplicative interaction (relative excess risk due to interaction [RERI] = 0.490, 95% CI 0.307–0.673; p for multiplicative interaction <.001) between napping and BFP, whereby a higher hazard of T2D associated with more frequent napping was greatest among participants in the highest BFP quartile (HR = 4.45, 95% CI: 3.92–5.06). The results for CRP were similar (RERI = 0.266, 95% CI: 0.094–0.439; p for multiplicative interaction <.001). CONCLUSIONS: Higher daytime napping frequency is associated with an increased T2D risk, and such relationships are modified by BFP and CRP. These findings underscore the importance of adiposity and inflammation control to mitigate diabetes risk.
format Online
Article
Text
id pubmed-10270744
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wiley Publishing Asia Pty Ltd
record_format MEDLINE/PubMed
spelling pubmed-102707442023-06-16 The association between daytime napping and risk of type 2 diabetes is modulated by inflammation and adiposity: Evidence from 435 342 UK‐Biobank participants Zhou, Rui Chen, Hao‐Wen Huang, Yi‐Ning Zhong, Qi Li, Fu‐Rong Huang, Rui‐Dian Liu, Hua‐Min Zheng, Jia‐Zhen Xu, Jia‐Wen Wu, Xian‐Bo J Diabetes Original Articles BACKGROUND: Existing evidence concerning the relationship between daytime napping and type 2 diabetes (T2D) is inconsistent, and whether the effects of napping differ by body fat percentage (BFP) and C‐reactive protein (CRP) is unclear. We aimed to investigate the association between daytime napping frequency and T2D risk and whether such an association was modified by BFP and CRP. METHODS: We included 435 342 participants free of diabetes from the UK Biobank. Participants were categorized as nonnappers, occasional nappers, and frequent nappers based on napping frequency, and BFP/CRP was divided into quartiles. Cox proportional hazards models were used. RESULTS: During a median follow‐up of 9.2 years, 17 592 T2D cases occurred. Higher frequency of daytime napping was significantly associated with an increased risk of T2D. Compared with nonnappers, the adjusted hazard ratios (HRs) for occasional nappers and habitual nappers were 1.28 (95% confidence interval [CI]: 1.24–1.32) and 1.49 (95% CI: 1.41–1.57), respectively. There was a significant additive and multiplicative interaction (relative excess risk due to interaction [RERI] = 0.490, 95% CI 0.307–0.673; p for multiplicative interaction <.001) between napping and BFP, whereby a higher hazard of T2D associated with more frequent napping was greatest among participants in the highest BFP quartile (HR = 4.45, 95% CI: 3.92–5.06). The results for CRP were similar (RERI = 0.266, 95% CI: 0.094–0.439; p for multiplicative interaction <.001). CONCLUSIONS: Higher daytime napping frequency is associated with an increased T2D risk, and such relationships are modified by BFP and CRP. These findings underscore the importance of adiposity and inflammation control to mitigate diabetes risk. Wiley Publishing Asia Pty Ltd 2023-04-13 /pmc/articles/PMC10270744/ /pubmed/37052293 http://dx.doi.org/10.1111/1753-0407.13387 Text en © 2023 The Authors. Journal of Diabetes published by Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Zhou, Rui
Chen, Hao‐Wen
Huang, Yi‐Ning
Zhong, Qi
Li, Fu‐Rong
Huang, Rui‐Dian
Liu, Hua‐Min
Zheng, Jia‐Zhen
Xu, Jia‐Wen
Wu, Xian‐Bo
The association between daytime napping and risk of type 2 diabetes is modulated by inflammation and adiposity: Evidence from 435 342 UK‐Biobank participants
title The association between daytime napping and risk of type 2 diabetes is modulated by inflammation and adiposity: Evidence from 435 342 UK‐Biobank participants
title_full The association between daytime napping and risk of type 2 diabetes is modulated by inflammation and adiposity: Evidence from 435 342 UK‐Biobank participants
title_fullStr The association between daytime napping and risk of type 2 diabetes is modulated by inflammation and adiposity: Evidence from 435 342 UK‐Biobank participants
title_full_unstemmed The association between daytime napping and risk of type 2 diabetes is modulated by inflammation and adiposity: Evidence from 435 342 UK‐Biobank participants
title_short The association between daytime napping and risk of type 2 diabetes is modulated by inflammation and adiposity: Evidence from 435 342 UK‐Biobank participants
title_sort association between daytime napping and risk of type 2 diabetes is modulated by inflammation and adiposity: evidence from 435 342 uk‐biobank participants
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270744/
https://www.ncbi.nlm.nih.gov/pubmed/37052293
http://dx.doi.org/10.1111/1753-0407.13387
work_keys_str_mv AT zhourui theassociationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT chenhaowen theassociationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT huangyining theassociationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT zhongqi theassociationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT lifurong theassociationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT huangruidian theassociationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT liuhuamin theassociationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT zhengjiazhen theassociationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT xujiawen theassociationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT wuxianbo theassociationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT zhourui associationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT chenhaowen associationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT huangyining associationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT zhongqi associationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT lifurong associationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT huangruidian associationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT liuhuamin associationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT zhengjiazhen associationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT xujiawen associationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants
AT wuxianbo associationbetweendaytimenappingandriskoftype2diabetesismodulatedbyinflammationandadiposityevidencefrom435342ukbiobankparticipants